Involvement of miR-214 and miR-375 in Malignant Features of Non-Small-Cell Lung Cancer by Down-Regulating CADM1

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Involvement of miR-214 and miR-375 in Malignant Features of Non-Small-Cell Lung Cancer by Down-Regulating CADM1"
written by Megumi Ishimura, Mika Sakurai-Yageta, Tomoko Maruyama, Tomoko Ando, Masashi Fukayama, Akiteru Goto, Yoshinori Murakami,
published by Journal of Cancer Therapy, Vol.3 No.4A, 2012

has been cited by the following article(s):

[1]	miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1
	Analytical Cellular …, 2021

[2]	MicroRNA-155-3p promotes breast cancer progression through down-regulating CADM1
	2019

[3]	miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms
	Oncology Reports, 2016

[4]	Promoter Methylation of the CADM1 and 4.1 B Genes Occurs Independently of the EGFR or the KRAS2 Mutation in Non-Small Cell Lung Cancer
	2015

[5]	miRNA-214: expression, therapeutic and diagnostic potential in cancer
	Tumori Journal, 2015

[6]	Promoter Methylation of the CADM1 and 4.1B Genes Occurs Independently of the EGFR or the KRAS2 Mutation in Non-Small Cell Lung Cancer
	Journal of Cancer Therapy, 2015

[7]	The role of a cell adhesion molecule, CADM1, in the internalization and degradation of EGFR
	2014

[8]	ヒト肺腺がんのゲフィチニブ耐性機構における細胞接着分子 CADM1 の意義
	2013

[1]	miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1 Analytical Cellular Pathology, 2021 DOI:10.1155/2021/7407086

[2]	miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms Oncology Reports, 2016 DOI:10.3892/or.2016.4854

[3]	miRNA-214: Expression, Therapeutic and Diagnostic Potential in Cancer Tumori Journal, 2015 DOI:10.5301/tj.5000318

[4]	Promoter Methylation of the CADM1 and 4.1B Genes Occurs Independently of the EGFR or the KRAS2 Mutation in Non-Small Cell Lung Cancer Journal of Cancer Therapy, 2015 DOI:10.4236/jct.2015.63030